Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacqueline Lehmann-Che

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
AIDS Reviews|February 11, 2005
Early stages of HIV replication: how to hijack cellular functions for a successful infectionJacqueline Lehmann-Che, Ali Saïb
Current Opinion in Microbiology|September 11, 2004
Foamy viruses--a world apartOlivier Delelis, Jacqueline Lehmann-Che, Ali Saïb
The New England Journal of Medicine|September 18, 2014
Resistance to therapy in acute promyelocytic leukemiaJacqueline Lehmann-Che, Cecile Bally, Hugues de Thé
Therapie|March 5, 2017
Cancer genomics guide clinical practice in personalized medicineJacqueline Lehmann-Che, Brigitte Poirot, Jean-Christophe Boyer, et al.
Therapie|February 7, 2017
Jacqueline Lehmann-Che, Brigitte Poirot, Jean Christophe Boyer, et al.
Cold Spring Harbor Perspectives in Medicine|December 6, 2015
p53 as an Effector or Inhibitor of Therapy ResponseJulien Ablain, Brigitte Poirot, Cécile Esnault, et al.
Medecine Sciences : M/S|November 21, 2007
[Exquisite sensitivity of TP53 mutant breast cancers to dose-dense chemotherapy]Jacqueline Lehmann-Che, Elisabeth Turpin, Philippe Bertheau, et al.
Breast Cancer Research : BCR|December 27, 2025
Molecular convergence of luminal androgen receptor and molecular apocrine defines a distinct entity in ER-negative breast tumorsAdrien Borgel, Etienne Camenen, Catherine Miquel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 7, 2017
MET Exon 14 Alterations and New Resistance Mutations to Tyrosine Kinase Inhibitors: Risk of Inadequate Detection with Current Amplicon-Based NGS PanelsBrigitte Poirot, Ludovic Doucet, Shirine Benhenda, et al.
Human Genetics|March 4, 2005
A neutral variant involved in a complex CFTR allele contributes to a severe cystic fibrosis phenotypeJérôme Clain, Jacqueline Lehmann-Che, Emmanuelle Girodon, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
AIDS Reviews|February 11, 2005
Early stages of HIV replication: how to hijack cellular functions for a successful infectionJacqueline Lehmann-Che, Ali Saïb
Current Opinion in Microbiology|September 11, 2004
Foamy viruses--a world apartOlivier Delelis, Jacqueline Lehmann-Che, Ali Saïb
The New England Journal of Medicine|September 18, 2014
Resistance to therapy in acute promyelocytic leukemiaJacqueline Lehmann-Che, Cecile Bally, Hugues de Thé
Therapie|March 5, 2017
Cancer genomics guide clinical practice in personalized medicineJacqueline Lehmann-Che, Brigitte Poirot, Jean-Christophe Boyer, et al.
Therapie|February 7, 2017
Jacqueline Lehmann-Che, Brigitte Poirot, Jean Christophe Boyer, et al.
Cold Spring Harbor Perspectives in Medicine|December 6, 2015
p53 as an Effector or Inhibitor of Therapy ResponseJulien Ablain, Brigitte Poirot, Cécile Esnault, et al.
Medecine Sciences : M/S|November 21, 2007
[Exquisite sensitivity of TP53 mutant breast cancers to dose-dense chemotherapy]Jacqueline Lehmann-Che, Elisabeth Turpin, Philippe Bertheau, et al.
Breast Cancer Research : BCR|December 27, 2025
Molecular convergence of luminal androgen receptor and molecular apocrine defines a distinct entity in ER-negative breast tumorsAdrien Borgel, Etienne Camenen, Catherine Miquel, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 7, 2017
MET Exon 14 Alterations and New Resistance Mutations to Tyrosine Kinase Inhibitors: Risk of Inadequate Detection with Current Amplicon-Based NGS PanelsBrigitte Poirot, Ludovic Doucet, Shirine Benhenda, et al.
Human Genetics|March 4, 2005
A neutral variant involved in a complex CFTR allele contributes to a severe cystic fibrosis phenotypeJérôme Clain, Jacqueline Lehmann-Che, Emmanuelle Girodon, et al.
Pageof 9